Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19.
Adult
Aged
Antibodies, Viral
/ blood
Betacoronavirus
/ immunology
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
/ methods
Coronavirus Infections
/ diagnosis
Female
Humans
Immunoassay
/ methods
Immunoglobulin G
/ blood
Immunoglobulin M
/ blood
Japan
Male
Middle Aged
Pandemics
Pneumonia, Viral
/ diagnosis
SARS-CoV-2
Sensitivity and Specificity
Thorax
/ diagnostic imaging
Tomography, X-Ray Computed
/ methods
COVID-19
Chest CT scan
Immunochromatographic assay
SARS-CoV-2
Journal
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
24
04
2020
accepted:
27
04
2020
pubmed:
11
5
2020
medline:
7
7
2020
entrez:
11
5
2020
Statut:
ppublish
Résumé
We evaluated the clinical performance of an immunochromatographic (IC) IgM/IgG antibody assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and chest computed tomography (CT) for the diagnosis of Coronavirus disease 2019 (COVID-19). We examined 139 serum specimens collected from 112 patients with COVID-19 and 48 serum specimens collected from 48 non-COVID-19 patients. The presence of IgM/IgG antibody for SARS-COV2 was determined using the One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test. Chest CT was performed in COVID-19 patients on admission. Of the139 COVID-19 serum specimens, IgM was detected in 27.8 %, 48.0 %, and 95.8 % of the specimens collected within 1 week, 1-2 weeks, and >2 weeks after symptom onset and IgG was detected in 3.3 %, 8.0 %, and 62.5 %, respectively. Among the 48 non-COVID-19 serum specimens, 1 generated a false-positive result for IgM. Thirty-eight of the 112 COVID-19 patients were asymptomatic, of whom 15 were positive for IgM, and 74 were symptomatic, of whom 22 were positive for IgM and 7 were positive for IgG. The diagnostic sensitivity of CT scan alone and in combination with the IC assay was 57.9 % (22/38) and 68.4 % (26/38) for the asymptomatic patients and 74.3 % (55/74) and 82.4 % (61/74) for the symptomatic patients, respectively. The IC assay had low sensitivity during the early phase of infection, and thus IC assay alone is not recommended for initial diagnostic testing for COVID-19. If RT-qPCR is not available, the combination of chest CT and IC assay may be useful for diagnosing COVID-19.
Sections du résumé
BACKGROUND
We evaluated the clinical performance of an immunochromatographic (IC) IgM/IgG antibody assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and chest computed tomography (CT) for the diagnosis of Coronavirus disease 2019 (COVID-19).
METHODS
We examined 139 serum specimens collected from 112 patients with COVID-19 and 48 serum specimens collected from 48 non-COVID-19 patients. The presence of IgM/IgG antibody for SARS-COV2 was determined using the One Step Novel Coronavirus (COVID-19) IgM/IgG Antibody Test. Chest CT was performed in COVID-19 patients on admission.
FINDINGS
Of the139 COVID-19 serum specimens, IgM was detected in 27.8 %, 48.0 %, and 95.8 % of the specimens collected within 1 week, 1-2 weeks, and >2 weeks after symptom onset and IgG was detected in 3.3 %, 8.0 %, and 62.5 %, respectively. Among the 48 non-COVID-19 serum specimens, 1 generated a false-positive result for IgM. Thirty-eight of the 112 COVID-19 patients were asymptomatic, of whom 15 were positive for IgM, and 74 were symptomatic, of whom 22 were positive for IgM and 7 were positive for IgG. The diagnostic sensitivity of CT scan alone and in combination with the IC assay was 57.9 % (22/38) and 68.4 % (26/38) for the asymptomatic patients and 74.3 % (55/74) and 82.4 % (61/74) for the symptomatic patients, respectively.
CONCLUSION
The IC assay had low sensitivity during the early phase of infection, and thus IC assay alone is not recommended for initial diagnostic testing for COVID-19. If RT-qPCR is not available, the combination of chest CT and IC assay may be useful for diagnosing COVID-19.
Identifiants
pubmed: 32387968
pii: S1386-6532(20)30135-9
doi: 10.1016/j.jcv.2020.104393
pmc: PMC7191278
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin G
0
Immunoglobulin M
0
Types de publication
Comparative Study
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
104393Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no conflicts of interests.
Références
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Radiology. 2020 Aug;296(2):E46-E54
pubmed: 32155105
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
J Med Virol. 2020 Oct;92(10):1724-1727
pubmed: 32227490
J Med Virol. 2020 Sep;92(9):1518-1524
pubmed: 32104917
Jpn J Radiol. 2020 May;38(5):391-393
pubmed: 32185669
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32229605
Radiology. 2020 Aug;296(2):E115-E117
pubmed: 32073353
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Radiology. 2020 Jun;295(3):715-721
pubmed: 32053470
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Radiology. 2020 Aug;296(2):E79-E85
pubmed: 32243238
J Infect Dis. 2020 May 11;221(11):1757-1761
pubmed: 32067043
Lancet Infect Dis. 2020 Apr;20(4):425-434
pubmed: 32105637
Radiology. 2020 Jun;295(3):200463
pubmed: 32077789
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Radiology. 2020 Apr;295(1):22-23
pubmed: 32049600
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510